Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2(4): 325-350.

Author(s): Mark C. Lavigne and Michael J Eppihimer.

Affiliation: Wyeth Research: Cardiovascular and Metabolic Diseases 200 Cambridge Park Drive Cambridge, Massachusetts 02140, USA.


The extravasation of leukocytes from the vascular to the interstitial compartment is a hallmark of the inflammatory response and is associated with the pathogenesis of many cardiovascular and immune-related diseases. Prior to their migration through the vessel wall, leukocytes undergo a series of adhesive interactions that begin as a rolling movement along the vascular endothelium, and are succeeded by stationary firm adhesion to the vessel wall. These rolling interactions are mediated primarily through low affinity interactions via the selectin (E-, L- and P-selectin) family of cell adhesion molecules, whereas firm adhesion between leukocytes and endothelial cells is mediated by the supergene immunoglobulins located on the surface on endothelial cells and their ligands, the integrins (β1, β2), located on leukocytes. The development of monoclonal antibodies and gene-targeted mice aimed at neutralizing these adhesive interactions have become powerful tools in examining the consequences of interfering with leukocyte-endothelial cell adhesion in the progression of many diseases, and validating their inhibition as a therapeutic targets. In recent years, significant efforts in developing small molecule antagonists and protein-engineered inhibitors against the selectins and integrin cell adhesion molecule families have been made. In this review, the available evidence concerning the role of leukocyte-endothelial cell adhesion in mediating vascular dysfunction and tissue necrosis in inflammatory diseases will be examined. Specifically, the development of leukocyte-endothelial cell adhesion inhibitors for the treatment of inflammatory diseases and their therapeutic benefits will be addressed.


leukocyte, endothelium, inflammation, adhesion, rolling, selectins, integrins.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 2
Issue Number: 4
First Page: 325
Last Page: 350
Page Count: 26
DOI: 10.2174/1568014033483635
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science